STOCK TITAN
  1. Home
  2. Sec-filings
  3. IMRN
  4. [6-K] Immuron Limited American Current Report (Foreign Issuer)

[6-K] Immuron Limited American Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock IMRN logo
Immuron Ltd

NASDAQ:IMRN

IMRN Rankings

#6015 Ranked by Market Cap
N/A Ranked by Dividends

IMRN Latest News

Aug 26, 2025
Immuron partners with InvestorHub
Jul 17, 2025
Immuron - FY25 global sales exceed projection, up 49% on prior year
May 30, 2025
Immuron Letter to Shareholders: Projects Update
Apr 10, 2025
Immuron Travelan® highest sales in history
Mar 5, 2025
Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)

IMRN Latest SEC Filings

Sep 2, 2025
[6-K] Immuron Limited American Current Report (Foreign Issuer)
Aug 26, 2025
[6-K] Immuron Limited American Current Report (Foreign Issuer)
Aug 15, 2025
[6-K] Immuron Limited American Current Report (Foreign Issuer)
Aug 13, 2025
[6-K] Immuron Limited American Current Report (Foreign Issuer)
Jul 21, 2025
[6-K] Immuron Limited American Current Report (Foreign Issuer)

IMRN Stock Data

10.83M
6.71M
0.34%
2.76%
Biotechnology
Healthcare
Link
Australia
Carlton